SCHEMBL27635367

SCHEMBL27635367

Cc1cnc2nc(Cl)ccc2c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 3/20 0.52
CCR5 P51681 3/20 0.52
CCR8 P51685 3/20 0.52
CYP1A2 P05177 3/20 0.42
KDM4E B2RXH2 3/20 0.38
PSMD14 O00487 1/20 0.38
COPS5 Q92905 1/20 0.38
CYP2A6 P11509 2/20 0.36
NOS3 P29474 2/20 0.34
NOS2 P35228 2/20 0.34
ALDH1A1 P00352 2/20 0.34
NCK1 P16333 1/20 0.33
BACE1 P56817 1/20 0.33
NOS1 P29475 1/20 0.33
AURKA O14965 1/20 0.33
PARP1 P09874 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28777985 0.79 NOS1 (0.39) CYP2A6NOS1AURKASMN1; SMN2
SCHEMBL29751072 0.79 NOS1 (0.39) CYP2A6NOS1AURKASMN1; SMN2
SCHEMBL12696174 0.79 CCR1 (0.56) CCR1CCR5CCR8CYP1A2KDM4E
SCHEMBL23360456 0.76 SMN1; SMN2 (0.38) CYP2A6ALDH1A1BACE1NOS1AURKA
SCHEMBL29862595 0.76 SMN1; SMN2 (0.38) CYP2A6ALDH1A1BACE1NOS1AURKA
SCHEMBL19001715 0.76 CCR1 (0.52) CCR1CCR5CCR8CYP1A2KDM4E
SCHEMBL12232242 0.76 CCR1 (0.52) CCR1CCR5CCR8CYP1A2KDM4E
SCHEMBL27940876 0.76 KDM4E (0.44) KDM4EAURKA
SCHEMBL25322668 0.76 RAB9A (0.40) CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL31010906 0.76 RAB9A (0.40) CYP1A2CYP2A6ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113620946-B Preparation method of 2-chloro-1, 8-naphthyridine derivatives 山东明化新材料有限公司 2022-06-21 CN claimed
CN-100422181-C [1,8] naphthyridin-2-ones and related compounds for the treatment of schizophrenia WARNER LAMBERT CO (US) 2008-10-01 CN disclosed
CN-1839134-A [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia WARNER LAMBERT CO (US) 2006-09-27 CN disclosed